CLINICAL POCT

Material Support for Clinical POCT and Multiplex Assays

Clinical POCT projects care about sensitivity, quantitative range, background control, reading stability and lot consistency. Materials should be validated together with instruments, algorithms, strip design and sample type.

MethodsColloidal gold, fluorescence LFA, time-resolved fluorescence, quantum dot and electrochemical immunochromatography.
TargetsCardiac markers, inflammation, viruses, tumor-related markers and multiplex panels.
FocusFluorescent beads, low-background backing, NC membrane, absorbent pads, cassettes and reading windows.
Material Support for Clinical POCT and Multiplex Assays

Material challenges

Clinical samples may contain proteins, lipids, blood cells and interfering substances that affect flow, background and signal stability. Multiplex assays add line-layout, release and signal-balancing complexity.

Validation should cover blank background, negative samples, low-value samples, linear range, repeatability, lot variation and accelerated stability.

Fluorescence and quantitative testing

Fluorescence lateral flow supports instrument readout, lower background and quantitative output. Particle size, surface group, coupling route and dispersion stability influence signal and consistency.

Backing cards, NC membranes, sample pads, conjugate pads and absorbent pads should be evaluated as one system.

Collaboration path

JY Biotech can support material screening, sample adoption, fluorescence project discussion, colloidal gold equipment, raw materials and bulk supply coordination.

FAQ

Why do backing cards and absorbent pads matter?

They affect background, running window, endpoint absorption and reading-region stability, especially in fluorescence and multiplex projects.

What is different in multiplex validation?

Multiple test lines require release balance, line layout, signal matching and reader-algorithm compatibility.